Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$22.43
-2.7%
$30.25
$22.07
$59.61
$1.09B1.38674,575 shs84,442 shs
Glaukos Co. stock logo
GKOS
Glaukos
$98.90
-2.0%
$92.21
$45.38
$103.66
$4.96B1.08657,777 shs95,407 shs
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$52.34
-0.3%
$49.24
$24.83
$54.79
$2.69B1.01494,192 shs121,424 shs
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$17.13
-2.5%
$17.52
$6.08
$45.08
$671.07M1.48788,231 shs246,118 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-0.52%-1.71%-18.29%-31.19%-44.84%
Glaukos Co. stock logo
GKOS
Glaukos
-0.03%+4.20%+13.95%+11.34%+113.01%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-2.36%+1.33%+11.64%+13.89%+46.96%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-0.57%+0.63%-4.67%+15.52%-60.51%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AtriCure, Inc. stock logo
ATRC
AtriCure
1.7137 of 5 stars
3.51.00.00.01.82.50.6
Glaukos Co. stock logo
GKOS
Glaukos
3.6414 of 5 stars
2.43.00.04.42.42.50.6
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.3816 of 5 stars
1.50.00.00.02.43.30.6
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
3.1931 of 5 stars
3.11.00.04.31.31.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
3.00
Buy$52.63134.62% Upside
Glaukos Co. stock logo
GKOS
Glaukos
2.78
Moderate Buy$99.800.91% Upside
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
3.00
Buy$45.60-12.88% Downside
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.18
Hold$22.1829.49% Upside

Current Analyst Ratings

Latest SILK, ATRC, GKOS, and PRCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
AtriCure, Inc. stock logo
ATRC
AtriCure
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$32.00
4/11/2024
Glaukos Co. stock logo
GKOS
Glaukos
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$85.00 ➝ $100.00
4/10/2024
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$46.00
4/8/2024
Glaukos Co. stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$110.00
4/3/2024
Glaukos Co. stock logo
GKOS
Glaukos
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$110.00
3/25/2024
Glaukos Co. stock logo
GKOS
Glaukos
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$107.00 ➝ $120.00
3/22/2024
Glaukos Co. stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$110.00
3/7/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $23.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $19.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.00 ➝ $18.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$399.24M2.72N/AN/A$9.84 per share2.28
Glaukos Co. stock logo
GKOS
Glaukos
$314.71M15.77N/AN/A$9.46 per share10.45
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$136.19M19.75N/AN/A$5.56 per share9.41
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M3.79N/AN/A$3.88 per share4.41

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$30.44M-$0.66N/AN/AN/A-7.62%-7.55%-5.83%5/1/2024 (Confirmed)
Glaukos Co. stock logo
GKOS
Glaukos
-$134.66M-$2.78N/AN/AN/A-42.79%-22.67%-11.50%5/1/2024 (Confirmed)
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$105.90M-$2.24N/AN/AN/A-77.75%-46.59%-30.63%5/1/2024 (Confirmed)
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.44N/AN/AN/A-31.70%-36.38%-21.41%4/30/2024 (Confirmed)

Latest SILK, ATRC, GKOS, and PRCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.20N/A+$0.20N/AN/AN/A  
5/1/2024N/A
Glaukos Co. stock logo
GKOS
Glaukos
-$0.59N/A+$0.59N/AN/AN/A  
5/1/2024N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.55N/A+$0.55N/AN/AN/A  
4/30/2024N/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40N/A+$0.40N/AN/AN/A  
2/28/2024Q4 2023
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million    
2/27/2024Q4 2023
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.44-$0.54-$0.10-$0.54$41.79 million$43.58 million      
2/21/2024Q4 2023
Glaukos Co. stock logo
GKOS
Glaukos
-$0.56-$0.63-$0.07-$0.51$81.00 million$82.40 million    
2/15/2024Q4 2023
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.22-$0.21+$0.01-$0.21$103.68 million$106.50 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Glaukos Co. stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.15
3.57
2.66
Glaukos Co. stock logo
GKOS
Glaukos
0.77
5.34
4.78
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.18
7.63
6.77
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.50
7.95
6.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Glaukos Co. stock logo
GKOS
Glaukos
99.04%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
89.46%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
3.20%
Glaukos Co. stock logo
GKOS
Glaukos
6.40%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
19.60%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
6.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,20048.38 million46.83 millionOptionable
Glaukos Co. stock logo
GKOS
Glaukos
90750.19 million46.98 millionOptionable
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
62651.40 million40.98 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
47439.18 million36.55 millionOptionable

SILK, ATRC, GKOS, and PRCT Headlines

SourceHeadline
Silk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceSilk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
globenewswire.com - April 23 at 4:30 PM
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to BuyAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
zacks.com - April 23 at 1:00 PM
Silk Road Medical (SILK) to Release Quarterly Earnings on TuesdaySilk Road Medical (SILK) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 23 at 4:32 AM
Silk Road Medical (SILK) to Release Earnings on TuesdaySilk Road Medical (SILK) to Release Earnings on Tuesday
marketbeat.com - April 23 at 4:30 AM
The Silk Road of the SeaThe Silk Road of the Sea
sundaytimes.lk - April 22 at 3:28 PM
Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.
nationalgeographic.com - April 22 at 3:28 PM
Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)
marketbeat.com - April 12 at 6:44 AM
Silk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from BrokeragesSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokerages
marketbeat.com - April 12 at 2:17 AM
Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%
marketbeat.com - April 11 at 12:45 PM
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
globenewswire.com - April 9 at 4:30 PM
Silk Road Medicals (SILK) New Launch to Aid Its TCAR PortfolioSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
zacks.com - April 8 at 11:25 AM
China, Sri Lanka forging stronger bondsChina, Sri Lanka forging stronger bonds
chinadaily.com.cn - April 7 at 3:48 PM
Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%
marketbeat.com - April 5 at 3:45 PM
Taiwan Earthquake: What to Know About Travel and How to HelpTaiwan Earthquake: What to Know About Travel and How to Help
msn.com - April 5 at 1:08 AM
The One and Only Benedict WongThe One and Only Benedict Wong
vulture.com - April 4 at 7:57 AM
Silk Road Medical Launches Enroute Transcarotid NPS PlusSilk Road Medical Launches Enroute Transcarotid NPS Plus
evtoday.com - April 4 at 7:57 AM
Worker injured by electric shock from power line in BiddefordWorker injured by electric shock from power line in Biddeford
finance.yahoo.com - April 3 at 11:54 AM
Silk Road launches next-gen transcarotid neuroprotection systemSilk Road launches next-gen transcarotid neuroprotection system
massdevice.com - April 3 at 11:54 AM
Ancient People Also Had Sunburns, So They Used These 4 Forms of ProtectionAncient People Also Had Sunburns, So They Used These 4 Forms of Protection
msn.com - April 3 at 6:53 AM
Traditional Chinese medicine gains wider recognition around worldTraditional Chinese medicine gains wider recognition around world
sb.by - April 3 at 6:53 AM
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
globenewswire.com - April 2 at 4:30 PM
Turkmenistan to launch traffic on Tejen - Mary expresswayTurkmenistan to launch traffic on Tejen - Mary expressway
en.trend.az - March 30 at 2:13 PM
Number of Russian Crocus City Hall terrorist attack victims increasesNumber of Russian Crocus City Hall terrorist attack victims increases
en.trend.az - March 30 at 2:13 PM
Rep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need A Global PerspectiveRep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need 'A Global Perspective'
theroot.com - March 29 at 2:31 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AtriCure logo

AtriCure

NASDAQ:ATRC
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Glaukos logo

Glaukos

NYSE:GKOS
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
PROCEPT BioRobotics logo

PROCEPT BioRobotics

NASDAQ:PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Silk Road Medical logo

Silk Road Medical

NASDAQ:SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.